Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial
2024 · Nature Cancer · 42 citations
https://doi.org/10.1038/s43018-024-00729-w
C
Chenguang Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
218
Papers
2.4K
Citations
28
h-index
54
i10-index
Chenguang Wang is an academic researcher from Beijing Institute of Technology. The author has contributed to research in topics: DNA and Nucleic Acid Chemistry & Gene expression and cancer classification & Molecular Biology Techniques and Applications. The author has an h-index of 28, co-authored 186 publications.
ORCID: 0000-0002-7085-3303Papers by this author
worksSTAT3 and NF-κB are Simultaneously Suppressed in Dendritic Cells in Lung Cancer
2017 · Scientific Reports · 35 citations
https://doi.org/10.1038/srep45395
Subnational estimation of modern contraceptive prevalence in five sub-Saharan African countries: a Bayesian hierarchical approach
2019 · BMC Public Health · 7 citations
https://doi.org/10.1186/s12889-019-6545-3
Fabrication of large-depth and multiscale gradient microstructure in dual-phase high entropy alloy via shock loading
2023 · Journal of Materials Research and Technology · 7 citations
https://doi.org/10.1016/j.jmrt.2023.09.243
Jointly Modeling Time‐To‐Event and Longitudinal Data With Individual‐Specific Change Points: A Case Study in Modeling Tumor Burden
2025 · Statistics in Medicine · 1 citations
https://doi.org/10.1002/sim.70021
Anti-tumor and antigen-specific CD8<sup>+</sup> T cell responses to TA-CIN/GPI-0100 vaccination in the TC-1 lung metastasis model.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0116389.g004
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat